Breaking News
Get 40% Off 0
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One Click Copy for Free
Close

Jin Yang Pharmaceutical Co Ltd (007370)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5,500 +30    +0.55%
07:01:59 - Closed. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7007370000 
  • Volume: 15,373
  • Bid/Ask: 5,510 / 5,520
  • Day's Range: 5,440 - 5,520
Jin Yang Pharmaceutical 5,500 +30 +0.55%

007370 Balance Sheet

 
Featured here, the Balance Sheet for Jin Yang Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2023
30/09
2023
30/06
2023
31/03
2022
31/12
Total Current Assets 56036.87 53491.23 49649.61 46328.55
Cash and Short Term Investments 13276.76 9800.53 11975.41 10494.37
Cash - - - -
Cash & Equivalents 3614.41 2404.05 3050.81 753.56
Short Term Investments 8400.24 6130 7052.93 7890
Total Receivables, Net 22971.78 23700.06 21457.95 20247.88
Accounts Receivables - Trade, Net 22548.37 23121.48 21034.19 19884.74
Total Inventory 19005.71 19170.33 16088.55 15423.41
Prepaid Expenses 15.8 26.13 34.27 42.83
Other Current Assets, Total 766.81 794.18 93.43 120.07
Total Assets 123682.16 121411.18 118113.2 114443.69
Property/Plant/Equipment, Total - Net 41941.57 42290.17 43600.4 43793.7
Property/Plant/Equipment, Total - Gross 63009.49 62691.64 63345.09 63459.37
Accumulated Depreciation, Total -21067.92 -20401.47 -19744.69 -19665.68
Goodwill, Net - - - -
Intangibles, Net 5495.31 5343.28 3971.03 3572.65
Long Term Investments 3717.43 3721.34 4301.03 4279.47
Note Receivable - Long Term 123.41 278.58 343.89 63.14
Other Long Term Assets, Total 15074.88 15072.7 15063.97 15062.16
Other Assets, Total 8179.18 5453.38 5255.66 6743.57
Total Current Liabilities 31235.17 32931.92 33474.55 30937.79
Accounts Payable 2707.42 4565.29 3174.43 2536.02
Payable/Accrued - - - -
Accrued Expenses 2925.46 2697.19 2242.46 2245.15
Notes Payable/Short Term Debt 19478.35 10441.23 20138.6 19530.28
Current Port. of LT Debt/Capital Leases 197.72 209.76 211.35 198.44
Other Current liabilities, Total 5926.21 15018.46 7707.71 6427.9
Total Liabilities 37151.69 38793.05 39390.37 36868.55
Total Long Term Debt 143.9 167.77 209.36 253.46
Long Term Debt - - - -
Capital Lease Obligations 143.9 167.77 209.36 253.46
Deferred Income Tax 4732.15 4656.25 4820.67 4756.54
Minority Interest - - - -
Other Liabilities, Total -18437.88 -9404.12 -19252.81 -18609.52
Total Equity 86530.47 82618.14 78722.83 77575.14
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 6000 6000 6000 6000
Additional Paid-In Capital 9625.3 9625.3 9625.3 9625.3
Retained Earnings (Accumulated Deficit) 61923.41 58011.08 53031.47 51883.86
Treasury Stock - Common -5643.33 -5643.33 -5643.33 -5643.33
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 14625.09 14625.09 15709.39 15709.3
Total Liabilities & Shareholders' Equity 123682.16 121411.18 118113.2 114443.69
Total Common Shares Outstanding 10.78 10.78 10.78 10.77
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

007370 Comments

Write your thoughts about Jin Yang Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email